Tag: global health
My first internship at the World Health Organisation – A formative experience and an education in the value of community-based medicine
In the most remote regions of the African continent, where healthcare centers and clinics are few and far between; where a journey on foot or on a bicycle to the nearest healthcare facility can easily last an entire day in the merciless, blistering heat of the sub-Saharan sun; too many children below the age of ...
Why Investors in the Pharmaceutical Industry Should Start Investing in Diseases Affecting Poor Countries.
Let’s discuss why investors in the pharmaceutical industry should start investing in drugs, therapeutics and medical devices aimed at treating, managing and ameliorating diseases affecting middle income countries in particular and the ‘global south’ in general.
The Basics: A beginners guide to acronyms and jargon
It’s been a while since I have published a “Basics” series article. I am grateful for the interest I have received on this humble blog of my musings in areas from economic development to novel treatment modes and health policy. Some of the feedback I have received has been concerning my occasionally excessive use of ...
Seven lessons I learned from Professor Hans Rosling: A Tribute
Last week we lost one of the greatest statisticians of our time. A clinician who informed scholars and audiences world over; and a researcher whose work on economic development and global health changed the way we view our world. Personally, too, I have lost a role model, Dr Hans Rosling of the Karolinska Institute. Nonetheless, ...
Hans Rosling: A Tribute
He was a clinician and statistician whose research and accessible insights changed the way we view the world, and our understandings of the complex relationships between development and health.
Rethinking Rabies: A Breakthrough in Management? – My comments on the literature
Rabies is a vaccine-preventable, zoonotic disease of global concern, resulting in over 55 000 deaths annually. Whilst standard post-exposure treatments are estimated to prevent hundreds of thousands of fatalities, these are not without shortcomings. Recent immunological research into novel treatments has revealed promising results. Published in the Journal of Infectious Diseases, the research paper this article comments on has been described as groundbreaking. (I dare say, most notably by those enchanted by the spell of the [magical] monoclonal antibody: still one of the coolest cocktail party topics in immunology.)
The Basics: Causes of Death
Everyone dies. And on more than a few occasions, I have heard the comments that all, in their own way, suggest that reducing mortality from specific disease causes is merely an exercise in pushing mortality from one disease cause to another; largely based on funding and location.
Tomorrow on the blog: Causes of Death
“He who has health has hope; and he who has hope has everything.” – Arabic Proverb Find the article here. 🙂
The Basics: The Paradox of the Dual Burden – NCDs and CDs
Here’s a fictional allegory: Thelma lives in a rural area in Tanzania. At age 5, she contracted malaria. Due to broadened availability of health services, Thelma received an artemisinin based treatment and, unlike many before her, she survived. In fact, she lived a long, healthy life. Long enough to reach the age of 55; at ...